Amithraz Balgobin, 36, allegedly attacked Amaratial Mistry at a property in Streatham, south London, on Friday July 4.

DEAR MISS MANNERS: I am a gentleman who strives to live a mannerly life. In that regard, when riding public transportation, I ...

There's a clear downside to the Norwegian policy that encourages allowing elderly people to live at home for as long as ...

Maria Pasqual was a flower farmer in Maili, loved by those who encountered her. The family who lives next door to her farm ...

The NYPD is searching for a suspect who assaulted a man in Brooklyn and has issued an appeal for public assistance. The ...

It’s very difficult to get a DMV appointment to stay compliant and get an enhanced or REAL ID, and some people in the ...

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel ...

A missing elderly woman with dementia has been found deceased in Daviess County. Lola Davis, 89, of Mt. Vernon, Indiana, went ...

The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...

The suspect told the victim to “shut up,'' sparking a dispute in which she became "aggressive'' and he walloped her multiple ...

FDA approval of EKTERLY makes KalVista Pharmaceuticals, Inc. the first to offer an oral on-demand HAE therapy. Click here to find out why KALV is a Strong Buy.

The Food and Drug Administration (FDA) has approved Ekterly ® (sebetralstat) for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.